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Background
The escalating cost of pharmaceuticals is a global chal-
lenge and major hindrance to access to medicines in
developing countries. Half of the Ugandan population
lacks reliable access to essential medicines and out of
pocket expenditure by patients is as high as 80% [1].
Generic medicines provide an opportunity for savings on
medicine expenditure due to their cheaper price [2,3].
Generic substitution has been recommended by World
Health Organisation and is widely practised in Africa as
long as the prescriber does not forbid nor the patient
decline [4]. Therefore, this study was conducted to deter-
mine the nature and prevalence of drug substitution in
community pharmacies in Kampala, the capital city of
Uganda. Dispensers’ perceptions were also explored.
Materials and methods
It was a cross sectional descriptive study employing two
data collection tools; a structured questionnaire adminis-
tered to dispensers in a random sample of community
pharmacies and simulated patients presenting with pre-
scriptions developed and validated by the research team.
Results
Up to 133 community pharmacies in Kampala city were
included in the study. Almost all (n=127, 96%) community
pharmacies practised drug substitution. The most com-
mon forms of drug substitution were innovator medicine
to generic medicine (85%) and generic medicine to other
generic medicine (82%). Up to 92% of the pharmacies sub-
stitute “over the counter” drugs while 56% substitute med-
icines on prescription. Only 24% of the pharmacies did
not consult the prescriber before drug substitution and
majority (75%) considered the price of the drug before
drug substitution. Knowledge of drug substitution policy
was low and many (61%) dispensers thought Uganda has
no national policy on drug substitution.
Conclusion
Drug substitution involving both innovator medicine to
generic medicine and generic to generic medicines is
wide spread in community pharmacies in Kampala city.
The drug regulatory authority should focus on thera-
peutic equivalence studies and safety profile of approved
generic products to better protect the public from sub-
standard medicines.
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